Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fagan

Showing results (251-260 of 489) with videos related to

Pageof 49
Sort By:
Neurobiology of Aging|June 19, 2016
NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkersStephanie J B Vos, Brian A Gordon, Yi Su, et al.
Archives of Neurology|December 17, 2009
Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer diseaseJohn C Morris, Catherine M Roe, Elizabeth A Grant, et al.
Neuropsychology|February 17, 2017
Process dissociation analyses of memory changes in healthy aging, preclinical, and very mild Alzheimer disease: Evidence for isolated recollection deficitsPeter R Millar, David A Balota, Geoffrey B Maddox, et al.
JAMA Neurology|March 29, 2016
Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer DiseaseRawan Tarawneh, Gina D'Angelo, Dan Crimmins, et al.
Plos One|May 24, 2013
Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variationRichard J Perrin, Jacqueline E Payton, James P Malone, et al.
EMBO Molecular Medicine|January 6, 2010
Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's diseaseAnne M Fagan, Mark A Mintun, Aarti R Shah, et al.
Archives of Neurology|September 14, 2011
Cerebrospinal fluid biomarkers, education, brain volume, and future cognitionCatherine M Roe, Anne M Fagan, Elizabeth A Grant, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|October 28, 1999
Patterns of medical student abuse during the internal medicine clerkship: perspectives of students at 11 medical schoolsD M Elnicki, B Linger, E Asch, et al.
Frontiers in Neuroscience|May 2, 2022
Plasma Neurofilament Light Chain Levels Are Elevated in Children and Young Adults With Wolfram SyndromeSarah A Eisenstein, Raveena S Boodram, Courtney L Sutphen, et al.
Neurobiology of Disease|February 15, 2022
Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damageKarin L Meeker, Omar H Butt, Brian A Gordon, et al.
Pageof 49

Showing results (251-260 of 489) with videos related to

Sort By:
Pageof 49
Neurobiology of Aging|June 19, 2016
NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkersStephanie J B Vos, Brian A Gordon, Yi Su, et al.
Archives of Neurology|December 17, 2009
Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer diseaseJohn C Morris, Catherine M Roe, Elizabeth A Grant, et al.
Neuropsychology|February 17, 2017
Process dissociation analyses of memory changes in healthy aging, preclinical, and very mild Alzheimer disease: Evidence for isolated recollection deficitsPeter R Millar, David A Balota, Geoffrey B Maddox, et al.
JAMA Neurology|March 29, 2016
Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer DiseaseRawan Tarawneh, Gina D'Angelo, Dan Crimmins, et al.
Plos One|May 24, 2013
Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variationRichard J Perrin, Jacqueline E Payton, James P Malone, et al.
EMBO Molecular Medicine|January 6, 2010
Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's diseaseAnne M Fagan, Mark A Mintun, Aarti R Shah, et al.
Archives of Neurology|September 14, 2011
Cerebrospinal fluid biomarkers, education, brain volume, and future cognitionCatherine M Roe, Anne M Fagan, Elizabeth A Grant, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|October 28, 1999
Patterns of medical student abuse during the internal medicine clerkship: perspectives of students at 11 medical schoolsD M Elnicki, B Linger, E Asch, et al.
Frontiers in Neuroscience|May 2, 2022
Plasma Neurofilament Light Chain Levels Are Elevated in Children and Young Adults With Wolfram SyndromeSarah A Eisenstein, Raveena S Boodram, Courtney L Sutphen, et al.
Neurobiology of Disease|February 15, 2022
Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damageKarin L Meeker, Omar H Butt, Brian A Gordon, et al.
Pageof 49